인쇄하기
취소
|
2 of 5 listed pharmaceutical companies were reportedly managed by more than 2 CEOs.
It seems the system spreads for the intent of responsibly running a company with separated roles between shareholders and professional managers.
Yakup Shinmoon(www.yakup.com) analyzed CEOs at 65 KOSPI and KOSDAQ listed pharmaceutical companies, and the analysis result showed that 37 pharmaceutical companies we...